Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Journal of Virology logoLink to Journal of Virology
. 1996 Oct;70(10):7108–7115. doi: 10.1128/jvi.70.10.7108-7115.1996

The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels.

G D Ewart 1, T Sutherland 1, P W Gage 1, G B Cox 1
PMCID: PMC190763  PMID: 8794357

Abstract

Vpu is a small phosphorylated integral membrane protein encoded by the human immunodeficiency virus type 1 genome and found in the endoplasmic reticulum and Golgi membranes of infected cells. It has been linked to roles in virus particle budding and degradation of CD4 in the endoplasmic reticulum. However, the molecular mechanisms employed by Vpu in performance of these functions are unknown. Structural similarities between Vpu and the M2 protein of influenza A virus have raised the question of whether the two proteins are functionally analogous: M2 has been demonstrated to form cation-selective ion channels in phospholipid membranes. In this paper we provide evidence that Vpu, purified after expression in Escherichia coli, also forms ion channels in planar lipid bilayers. The channels are approximately five- to sixfold more permeable to sodium and potassium cations than to chloride or phosphate anions. A bacterial cross-feeding assay was used to demonstrate that Vpu can also form sodium-permeable channels in vivo in the E. coli plasma membrane.

Full Text

The Full Text of this article is available as a PDF (320.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bour S., Schubert U., Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J Virol. 1995 Mar;69(3):1510–1520. doi: 10.1128/jvi.69.3.1510-1520.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Duff K. C., Ashley R. H. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology. 1992 Sep;190(1):485–489. doi: 10.1016/0042-6822(92)91239-q. [DOI] [PubMed] [Google Scholar]
  3. Friborg J., Ladha A., Göttlinger H., Haseltine W. A., Cohen E. A. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):10–22. [PubMed] [Google Scholar]
  4. Haddock B. A., Downie J. A. The reconstitution of functional respiratory chains in membranes from electron-transport-deficient mutants of Escherichia coli as demonstrated by quenching of atebrin fluorescence. Biochem J. 1974 Sep;142(3):703–706. doi: 10.1042/bj1420703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hay A. J., Wolstenholme A. J., Skehel J. J., Smith M. H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985 Nov;4(11):3021–3024. doi: 10.1002/j.1460-2075.1985.tb04038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Helenius A. Unpacking the incoming influenza virus. Cell. 1992 May 15;69(4):577–578. doi: 10.1016/0092-8674(92)90219-3. [DOI] [PubMed] [Google Scholar]
  7. Jabbar M. A. The human immunodeficiency virus type 1 Vpu protein: roles in virus release and CD4 downregulation. Curr Top Microbiol Immunol. 1995;193:107–120. doi: 10.1007/978-3-642-78929-8_6. [DOI] [PubMed] [Google Scholar]
  8. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol. 1990 Feb;64(2):621–629. doi: 10.1128/jvi.64.2.621-629.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levy J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993 Mar;57(1):183–289. doi: 10.1128/mr.57.1.183-289.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lu Y. A., Clavijo P., Galantino M., Shen Z. Y., Liu W., Tam J. P. Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system. Mol Immunol. 1991 Jun;28(6):623–630. doi: 10.1016/0161-5890(91)90131-3. [DOI] [PubMed] [Google Scholar]
  11. Maldarelli F., Chen M. Y., Willey R. L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol. 1993 Aug;67(8):5056–5061. doi: 10.1128/jvi.67.8.5056-5061.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Piller S. C., Ewart G. D., Premkumar A., Cox G. B., Gage P. W. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):111–115. doi: 10.1073/pnas.93.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pinto L. H., Holsinger L. J., Lamb R. A. Influenza virus M2 protein has ion channel activity. Cell. 1992 May 1;69(3):517–528. doi: 10.1016/0092-8674(92)90452-i. [DOI] [PubMed] [Google Scholar]
  14. Sansom M. S., Kerr I. D. Influenza virus M2 protein: a molecular modelling study of the ion channel. Protein Eng. 1993 Jan;6(1):65–74. doi: 10.1093/protein/6.1.65. [DOI] [PubMed] [Google Scholar]
  15. Schroeder C., Ford C. M., Wharton S. A., Hay A. J. Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity. J Gen Virol. 1994 Dec;75(Pt 12):3477–3484. doi: 10.1099/0022-1317-75-12-3477. [DOI] [PubMed] [Google Scholar]
  16. Schubert U., Bour S., Ferrer-Montiel A. V., Montal M., Maldarell F., Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol. 1996 Feb;70(2):809–819. doi: 10.1128/jvi.70.2.809-819.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schubert U., Henklein P., Boldyreff B., Wingender E., Strebel K., Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol. 1994 Feb 11;236(1):16–25. doi: 10.1006/jmbi.1994.1114. [DOI] [PubMed] [Google Scholar]
  18. Schubert U., Schneider T., Henklein P., Hoffmann K., Berthold E., Hauser H., Pauli G., Porstmann T. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur J Biochem. 1992 Mar 1;204(2):875–883. doi: 10.1111/j.1432-1033.1992.tb16707.x. [DOI] [PubMed] [Google Scholar]
  19. Skehel J. J. Influenza virus. Amantadine blocks the channel. Nature. 1992 Jul 9;358(6382):110–111. doi: 10.1038/358110b0. [DOI] [PubMed] [Google Scholar]
  20. Strebel K., Klimkait T., Maldarelli F., Martin M. A. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol. 1989 Sep;63(9):3784–3791. doi: 10.1128/jvi.63.9.3784-3791.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Strebel K., Klimkait T., Martin M. A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 1988 Sep 2;241(4870):1221–1223. doi: 10.1126/science.3261888. [DOI] [PubMed] [Google Scholar]
  22. Sugrue R. J., Bahadur G., Zambon M. C., Hall-Smith M., Douglas A. R., Hay A. J. Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 1990 Nov;9(11):3469–3476. doi: 10.1002/j.1460-2075.1990.tb07555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sugrue R. J., Hay A. J. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology. 1991 Feb;180(2):617–624. doi: 10.1016/0042-6822(91)90075-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sunstrom N. A., Premkumar L. S., Premkumar A., Ewart G., Cox G. B., Gage P. W. Ion channels formed by NB, an influenza B virus protein. J Membr Biol. 1996 Mar;150(2):127–132. doi: 10.1007/s002329900037. [DOI] [PubMed] [Google Scholar]
  25. Terwilliger E. F., Cohen E. A., Lu Y. C., Sodroski J. G., Haseltine W. A. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5163–5167. doi: 10.1073/pnas.86.13.5163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tosteson M. T., Pinto L. H., Holsinger L. J., Lamb R. A. Reconstitution of the influenza virus M2 ion channel in lipid bilayers. J Membr Biol. 1994 Oct;142(1):117–126. doi: 10.1007/BF00233389. [DOI] [PubMed] [Google Scholar]
  27. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell. 1995 Jul 28;82(2):189–192. doi: 10.1016/0092-8674(95)90306-2. [DOI] [PubMed] [Google Scholar]
  28. Varadhachary A., Maloney P. C. A rapid method for reconstitution of bacterial membrane proteins. Mol Microbiol. 1990 Aug;4(8):1407–1411. doi: 10.1111/j.1365-2958.1990.tb00720.x. [DOI] [PubMed] [Google Scholar]
  29. Wang C., Lamb R. A., Pinto L. H. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells. Virology. 1994 Nov 15;205(1):133–140. doi: 10.1006/viro.1994.1628. [DOI] [PubMed] [Google Scholar]
  30. Willey R. L., Maldarelli F., Martin M. A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol. 1992 Dec;66(12):7193–7200. doi: 10.1128/jvi.66.12.7193-7200.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yamato I., Kotani M., Oka Y., Anraku Y. Site-specific alteration of arginine 376, the unique positively charged amino acid residue in the mid-membrane-spanning regions of the proline carrier of Escherichia coli. J Biol Chem. 1994 Feb 25;269(8):5720–5724. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES